These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31176541)

  • 21. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes.
    Verger JM; Grayon M; Zundel E; Lechopier P; Olivier-Bernardin V
    Vaccine; 1995 Feb; 13(2):191-6. PubMed ID: 7625115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What have we learned from brucellosis in the mouse model?
    Grilló MJ; Blasco JM; Gorvel JP; Moriyón I; Moreno E
    Vet Res; 2012 Apr; 43(1):29. PubMed ID: 22500859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide as a target for brucellosis vaccine design.
    Conde-Álvarez R; Arce-Gorvel V; Gil-Ramírez Y; Iriarte M; Grilló MJ; Gorvel JP; Moriyón I
    Microb Pathog; 2013 May; 58():29-34. PubMed ID: 23219811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping.
    Miranda KL; Poester FP; Minharro S; Dorneles EM; Stynen AP; Lage AP
    Vaccine; 2013 Jun; 31(29):3014-8. PubMed ID: 23664986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
    Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
    Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
    Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confronting the barriers to develop novel vaccines against brucellosis.
    Oliveira SC; Giambartolomei GH; Cassataro J
    Expert Rev Vaccines; 2011 Sep; 10(9):1291-305. PubMed ID: 21919619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Brucellosis Vaccines: A Comprehensive Review.
    Heidary M; Dashtbin S; Ghanavati R; Mahdizade Ari M; Bostanghadiri N; Darbandi A; Navidifar T; Talebi M
    Front Vet Sci; 2022; 9():925773. PubMed ID: 35923818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis).
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Adone R
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):43-55. PubMed ID: 16112746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J
    Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brucella: a Mr "Hide" converted into Dr Jekyll.
    Gorvel JP
    Microbes Infect; 2008 Jul; 10(9):1010-3. PubMed ID: 18664389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenic response induced by wzm and wzt gene deletion mutants from Brucella abortus S19.
    Wang XR; Yan GM; Zhang R; Lang XL; Yang YL; Li XY; Chen S; Qian J; Wang XL
    Mol Med Rep; 2014 Feb; 9(2):653-8. PubMed ID: 24247358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.